Damijan Knez

Ljubljana, 1000, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.

Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

Structure-Activity Relationship and Crystallographic Study of New Monobactams.

Structure-Activity Relationship and Crystallographic Study of New Monobactams.

Journal: Journal of medicinal chemistry

Published: February 03, 2026

edXTrace: A ray tracing software tool for correcting absorption effects and detector shadowing for EDXS quantification in the TEM.

edXTrace: A ray tracing software tool for correcting absorption effects and detector shadowing for EDXS quantification in the TEM.

Journal: Ultramicroscopy

Published: January 14, 2026

Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking Approaches.

Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking Approaches.

Journal: ChemMedChem

Published: December 21, 2025

Carbamoyl fluorides as serine hydrolase inhibitors: a case study on FphI from Staphylococcus aureus.

Carbamoyl fluorides as serine hydrolase inhibitors: a case study on FphI from Staphylococcus aureus.

Journal: Bioorganic chemistry

Published: November 20, 2025

Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and α7 nicotinic receptor.

Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and α7 nicotinic receptor.

Journal: Chemico-biological interactions

Published: September 18, 2025

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 08, 2025

Transforming ureas into carbamates: From allosteric p38α MAPK ligands to dual BChE/p38α MAPK inhibitors.

Transforming ureas into carbamates: From allosteric p38α MAPK ligands to dual BChE/p38α MAPK inhibitors.

Journal: Bioorganic chemistry

Published: July 14, 2025

N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors.

N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors.

Journal: Chemico-biological interactions

Published: June 30, 2025

Expanding the reactive chemistry toolbox - warhead screening for covalent butyrylcholinesterase inhibitors.

Expanding the reactive chemistry toolbox - warhead screening for covalent butyrylcholinesterase inhibitors.

Journal: Chemico-biological interactions

Published: June 17, 2025

α-Heteroarylthiomethyl ketones: Small molecule inhibitors of 3CLpro.

α-Heteroarylthiomethyl ketones: Small molecule inhibitors of 3CLpro.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: June 06, 2025

Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.

Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: June 02, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026